Breaking News, Promotions & Moves

Evotec CEO Returns

Lanthaler resumes his role following sick leave

Dr. Werner Lanthaler, chief executive officer of Evotec will resume his role following a period of leave due to health reasons. Dr. Flemming Ornskov, chairman of the supervisory board of Evotec, said, “The board is delighted to welcome back Dr. Lanthaler to resume his leadership of Evotec and to continue to drive the growth of the Company through Action Plan 2016. The board would also like to thank the management team of Colin Bond, Dr. Cord Dohrmann and Dr. Mario Polywka for managing the company in Dr. Lanthaler’s absence.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters